Project: Development of molecular target-oriented recombinant antibodies as innovative therapeutics against promestatic and proangiogenic mediators of cancer microenvironment.
| Acronym | ETB-2006-048 |
| Network | EUROTRANSBIO |
| Call | 1st Call for proposals (Call 2006) |